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1. Introduction 
During the normal development of the retinal 
pigment epithelium (RPE) of the chick embryo, 
observed rates of melanin synthesis go through two 
stages. The time of transition from low to high rates, 
at approx. 4.5 days, is linked to the withdrawal of 
cells from mitotic activity which begins at approx. 
3.5 days [l]. These observations pose several questions 
directly related to the manufacture of the mRNA 
needed for melanosomal protein synthesis. First, while 
the cells are still dividing, and are making melanin at 
low rates, is new mRNA manufactured which is 
needed for maintaining the low levels of melanogenesis 
observed. Second, it is not known if de novo mRNA 
synthesis is required for the changeover to high level 
melanogenesis, or if an already existing but unutilized 
pool of mRNA is available. Alternatively, there could 
be a speedup in the translation rate of already extant 
message. 
In an attempt to determine the answers to these 
questions, mRNA synthesis was selectively blocked 
with a-amanitin 12-41. The results indicate that the 
mRNA needed for low level melanogenesis is present 
prior to the time when melanin can first be measured 
biochemically. Furthermore, it appears that the mRNA 
needed for increased melanogenesis is made shortly 
after the cells withdraw from mitotic activity and 
approximately 18-24 h prior to any measurable 
increase in melanin synthesis. 
That these effects are not due to differences in 
cY_amanitin uptake or effectiveness between different- 
aged embryos is determined on a general level. 
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Observations on the effect of a-amanitin on the rates 
of total RNA and protein synthesis indicate that the 
rates are the same for equivalent exposure times 
regardless of the age of the embryo. 
2. Materials and methods 
2.1. Staging and treatment of eggs 
White Leghorn eggs were staged and drugs were 
added as previously described [ 1,5]. The a-amanitin 
dose was 0.5 lg/egg (a sublethal dose) and well below 
the high dose levels usually observed to inhibit RNA 
polymerase activity other than polymerase 11 [3,4,6,7] 
2.2. Thiouracil assay 
Thiouracil (TU) has previously been shown to be 
effective in specifically measuring the rate of melanin 
synthesis [ 1,8] in embryos three days or older. 
Although its site of attachment is unknown at this 
time, it has been shown to bind to melanin only 
during manufacture, not to already synthesized 
melanin. Furthermore, its binding has been demon- 
strated to be specific. For this work, either 2-thio- 
[2-14C]uracil (Amersham/Searle; 61 mCi/mmol) or 
2- [35S]thiouracil (Amersham/Searle; 12 mCi/mmol) 
was added directly to each egg. For [14C]TU, the dose 
was 0.5 PCi; for [3sS]TU, the dose was 5.0 $i. (To 
ensure that the observed results were not due to 
differences in the labelling of the compound, the 
experiments done with [ 14C]TU were repeated using 
[3sS]TU.) After addition, the eggs were maintained as 
usual in a humidified egg incubator. At the end of the 
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incubation period, the eyes were removed, washed 
2-4 X in cold 12% trichloracetic acid (TCA) and 
prepared for scintillation counting as previously 
described [ 11. Data from 4 eyes, in duplicate, were 
pooled and expressed as a percentage of the control 
value. 
Table 1 
Effect of ol-amanitin on’low level melanogenesis 
Age (days) at a-amanitin % Control value 
addition melanin synthesis 
2.3. Uridine incorporation 
Eggs were treated with cr-amanitin for times stated. 
At the end of the given time period, the eyes, and 
eyes from untreated embryos of the same age, were 
placed in 0.2 ml carrier medium [ 11, containing 60 &i 
[3H]uridine ( [.5,6-3H]uridine; Amersham/Searle; 41.5 
Ci/mmol) and for the cy-amanitin treated eyes, 0.1 pg 
cw-amanitin/ml, for 15 min at 37°C. Tissue was then 







wAmanitin added at the age indicated. At 3.50 days all eggs 
and one set of untreated eggs receive labeled TU. At the end 
of 5 h, the tissue was processed for scintillation counting as 
previously described [ 11. Data are expressed as percent of 
incorporation of 3.50 day untreated tissue, average of 2 
experiments 
2.4. Leucine incorporation 
Eggs were treated with a-amanitin for times 
stated. At the end of the time period, 20 /_&i [3H]leu- 
tine (L[3,4,5-3H]leucine, 78.2 Ci/mmol, New England 
Nuclear) were added to each egg. After 4 h incubation 
time, the eyes were removed, washed 2X in 12% TCA 
and prepared for scintillation counting. 
3. Results 
could occur. First, there may be a long-lived mRNA 
present throughout the whole time period, making it 
unnecessary to continually manufacture new message 
and thus, the cr-amanitin treatment time was too short 
to be effective. The second possibility is that it takes 
longer than 24 h to get from synthesis of rhe message 
to biochemically measurable product, again making 
the cr-amanitin-treatment time too short. By examining 
the effect of a-amanitin when new message should be 
needed for the transition from low to high rates, some 
idea of which of these two possibilities is correct may 
be discerned. 
3.1. Manufacture of mRNA during low level melano- 
genesis 3.2. Manufacture of mRNA necessary for increased 
There is evidence that the cells of the RPE are 
determined to make melanin as early as 2-2.5 days 
([ 11, Zimmerman, Brumbaugh and Strahs, unpublished 
results). Therefore, eggs of 2.5, 2.75, 3.0 and 3.25 
days of incubation each received 0.5 1.18 of cw-amanitin. 
At 3.5 days of incubation, viable eggs received 5 UCi 
of [35S]TU for 5 h as did a set of untreated 3.5 day- 
old eggs, viability being measured by a continuing 
heart beat. 
melanogenesis 
The results are shown in table 1 (the amount of 
label incorporated in the untreated 3.5 day embryos 
is used as 100% in order to normalize the data). The 
results clearly indicate that at no time in the 24 h 
preceding 3.5 days was melanin synthesis blocked 
by adding cY-amanitin. (Possible reasons for the 
apparent stimulation of melanin synthesis are discussed 
below.) There are several possible ways by which this 
At approximately 4.5 days of development, there 
is a rapid increase in the rate of melanin synthesis in 
the chick RPE. This increase is linked to a withdrawal 
of the cells from mitotic activity at approx. 3.5 days 
of development, and shifts in withdrawal have been 
shown to result in concomitant shifts in melanogenic 
rates [ 11. This suggests that those factors which control 
the mRNA necessary for this increase (i.e., its synthesis, 
release from a pool or increased translation rate) come 
into play after withdrawal, at 3.5 days or later. 
In accordance with this, e-amanitin was added at 
3.5, 3.75,4.0 and 4.25 days of development. At 4.5 
days, all of the above, plus an untreated set of eggs, 
received labeled TU (either 14C or 35S, depending 
upon the run) for 8 h. The averaged results for all four 
runs are shown in table 2, column 2. (There was no 
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Table 2 
Effect of ol-amanitin during high level melanogenesis 
Measurement at 4.5 days 
Age (days) at cu-amanitin Melanin Measurement at 5.0 days 
addition synthesis [ ‘H]Uridine [ 3H]Leucine melanin synthesis 
3.5 51.5 105.8 105.8 165.0 
3.75 81.3 - - 156.5 
4.0 102.7 70.7 100.0 208.5 
4.25 97.5 - - 151.0 
4.5 100.0 100.0 100.0 - 
5.0 - - 100.0 
or-Amanitin added at age indicated. At either 4.5 or 5.0 days of incubation, melanin synthesis measured or 
total RNA or protein synthesis measured (see Materials and methods, table 3). Data expressed as percent 
(ol-amanitin treated)/(control). Melanin synthesis at 4.5 days average of 4 experiments, all others average of 
2 experiments 
notable difference between the use of t3’S] - and 
[14C]TU.) It is clear from the results that the addition 
of a-amanitin at 3.5 days results in a significant 
decrease in the amount of melanin synthesized at 
4.5 days. The addition of o-amanitin later than 3.75 
days has no discernible effect on the rate of melanin 
synthesis. 
In order to insure that this lack of effect is not due 
to a failure of a-amanitin to enter, or act upon, older 
embryos, 3.5 and 4.0 day eggs received a-amanitin. 
(These points were chosen as representatives of those 
times at which cY-amanitin affects melanin synthesis 
and those times it does not.) At the end of the given 
times (table 3) both treated and untreated eyes 
received either [3H]leucine or [3H]uridine. The results 
show that cu-amanitin acts on both ages in a similar 
fashion. Total RNA synthesized after 4 h is reduced 
by about 50%, while after 24 h the rate of total RNA 
synthesis is at approximately the same levels as the 
controls. Protein synthesis remains in the 90-100% 
range for all times measured. 
Therefore, the lack of ol-amanitin effect on 4.0 day 
or older animals, or, if the mRNAs are the same, in 
2.5-3.25 day animals, probably cannot be attributed 
to a failure of the drug to affect RNA synthesis in 
those animals. Furthermore, the similar effect, after 
a given time period, in both 3.5 and 4.0 day animals 
on RNA and protein synthesis indicates that a-amanitin 
is acting similarly upon them. 
The above results suggest he existence of long-lived 
Table 3 




(Exposure time to a-amanitin) 
4h 24 h 
[ “H] Leucine 
(Exposure time to ol-amanitin) 
4h 12h 
3.5 49.9 105.8 99.9 87.7 
4.0 48.7 119.7 90.7 100.0 
3.5 and 4.0 day eggs received or-amanitin for indicated time. At the end of that time: (1) the 
eyes were removed and they and the control eyes were incubated in [ ‘Hluridine containing 
medium for 15 min or (2) the eggs received [ ‘Hlleucine for 4 h. After the exposure to label, the 
eyes were prepared for scintillation counting. Data are expressed as percent (ol-amanitin treated)/ 
(control) 
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mRNA. It may be tested for by blocking mRNA 
manufacture and waiting a period of time sufficient 
to significantly decrease the proportion of short-lived 
mRNA present; this should favor the translation rate 
of the long-lived mRNA population. Then, by extending 
the period of time of cy-amanitin exposure, one should 
increase the percentage of melanin manufactured 
relative to the controls. 
The results shown in table 2, column 5, represent a 
36 h maximum exposure to cu-amanitin prior to 
measurement. In comparing columns 2 and 5, it is 
clear that where addition of a-amanitin at 3.5 days and 
measurement at 4.5 days results in a decreased manu- 
facture, relative to controls, an extension of 12 h, i. e., 
measurement at 5 days, results in an increased level of 
activity. 
4. Discussion 
The results presented in this paper support the 
idea that transcriptional control of new mRNA is, 
in fact, involved in the change from low to high 
melanogenic rates, and that this occurs between 3.5 
and 3.75 days (table 2). (That this does not continue 
to occur later is suggested by the failure of o-amanitin 
treatment at 4.0 days to decrease the rate of synthesis 
at 5.0 days.) Treatment of eggs with o-amanitin at 
3.5 days results in a marked decrease in the ability of 
the RPE to produce melanin at 4.5 days. Treatment 
with o-amanitin at later times results in a decreasing 
inhibition when measured at 4.5 days. 
The results presented in table 1 of this paper 
suggest hat all the mRNA needed for low level melano- 
genesis is in existence prior to 2.5 days of development. 
This requires the existence of a long-lived mRNA or a 
transcription-to-finished-product ime greater than 24 h. 
Assuming that the mRNA involved in the results in 
tables 1 and 2 are the same would rule out the possi- 
bility that the transcription-to-measurement time is 
greater than 24 h. This leaves the idea that the mRNA 
involved in melanin synthesis is long-lived, which in 
light of the findings concerning, for example, possible 
myeloma mRNA [9] and fibroin mRNA [lo], is not 
surprising. 
The idea of a long-lived mRNA is further supported 
by the fact that the data indicate the possibility of a 
selective effect of cY-amanitin in reducing the short- 
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lived mRNA population and so effectively increasing 
the rate at which long-lived mRNA is read and trans- 
lated (table 2, column 5). Furthermore, the data 
presented in table 2, columns 3 and 4, add additional 
support to this idea. In these columns total RNA and 
protein synthesis were measured at the same time as 
melanin synthesis was measured, and thus after 
different times of exposure to cu-amanitin. Protein 
synthesis again remains unaffected by exposure to 
cw-amanitin. Total RNA however seems to vary 
inversely with melanin synthesis. If total RNA synthesis 
is a measure of melanin related mRNA synthesis, then 
this effect is inconsistent with melanin mRNAs being 
short-lived. If they were short-lived then the decrease 
shown in total RNA for the 4.0 day embryos should 
be reflected as a decrease in melanin synthesis, while 
exactly the opposite should be the case for the 3.5 
day embryos. That this is not true is consistent with 
the idea that long-lived mRNA is involved and that it 
is synthesized prior to 4.0 days of development. (If 
total RNA synthesis is not a measure of melanin 
related mRNA synthesis, then the data need only be 
examined as it relates to table 3.) 
These results and discussion do not preclude the 
possible existence of a pool of mRNA synthesized but 
unutilized during low level melanogenesis, whose 
release is somehow stimulated by cr-amanitin, but at 
least make it unlikely since during high level melano- 
genesis cr-amanitin initially blocks the production of 
normal levels of melanin and this suggests a require- 
ment for synthesis of new message. To come to 
deiinitive conclusions on these points requires the 
isolation of melanosomal proteins and their mRNA. 
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